Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis.

Saved in:
Bibliographic Details
Title: Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis.
Authors: Spiera R; Weill Cornell Medical College, New York, New York., Kuwana M; Nippon Medical School Graduate School of Medicine, Tokyo, Japan., Khanna D; University of Michigan, Ann Arbor., Hummers L; John Hopkins University School of Medicine, Baltimore, Maryland., Frech TM; University of Utah and Salt Lake City VA Health Care System, Salt Lake City, Utah., Stevens W; St. Vincent's Hospital, Melbourne, Victoria, Australia., Matucci-Cerinic M; Department of Experimental and Clinical Medicine, University of Florence, and Division of Rheumatology AOUC, Florence, and Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), IRCCS San Raffaele Hospital, Milan, Italy., Kafaja S; David Geffen School of Medicine at University of California, Los Angeles (UCLA)., Distler O; University Hospital Zurich, University of Zurich, Zurich, Switzerland., Jun JB; Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea., Levy Y; Meir Medical Center, Kfar Saba, Israel., Leszcyzński P; Medyczne Centrum Hetmanska, Poznan, Poland., Gordon J; Weill Cornell Medical College, New York, New York., Steen V; Georgetown University School of Medicine, Washington, DC., Lee EB; Seoul National University College of Medicine, Seoul, South Korea., Jankowski T; Klinika Reumatologii Ukladowych Chorob Tkanki Lacznej Szpital Uniwersytecki, Bydgozzcz, Poland., Litinsky I; Tel Aviv Sourasky Medical Center, Tel Aviv, Israel., Chung L; Stanford University School of Medicine and Palo Alto VA Health Care System, Palo Alto, California., Hsu V; Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey., Mayes M; McGovern Medical School, The University of Texas Health Science Center at Houston., Sandorfi N; Perelman School of Medicine at the University of Pennsylvania, Philadelphia., Simms RW; Boston University School of Medicine, Boston, Massachusetts., Finzel S; Department of Rheumatology and Clinical Immunology, University Medical Center, Universitätsklinikum Freiburg, Freiburg, Germany., de Vries-Bouwstra J; Leiden University Medical Center, Leiden, The Netherlands., Constantine S; Corbus Pharmaceuticals, Inc., Norwood, Massachusetts., Dgetluck N; Corbus Pharmaceuticals, Inc., Norwood, Massachusetts., Dinh Q; Corbus Pharmaceuticals, Inc., Norwood, Massachusetts., Bloom BJ; Corbus Pharmaceuticals, Inc., Norwood, Massachusetts., Furst DE; Department of Experimental and Clinical Medicine, University of Florence, and Division of Rheumatology AOUC, Florence, Italy, David Geffen School of Medicine at UCLA, Los Angeles, California, and University of Washington, Seattle, UK., White B; Corbus Pharmaceuticals, Inc., Norwood, Massachusetts., Denton CP; UCL Centre for Rheumatology and Connective Tissue Diseases, Royal Free Hospital Campus, University College London Medical School, London, UK.
Corporate Authors: RESOLVE-1 Study Group
Source: Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2023 Sep; Vol. 75 (9), pp. 1608-1618. Date of Electronic Publication: 2023 Jun 15.
Publication Type: Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101623795 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2326-5205 (Electronic) Linking ISSN: 23265191 NLM ISO Abbreviation: Arthritis Rheumatol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37098795
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Spiera+R%22">Spiera R</searchLink>; Weill Cornell Medical College, New York, New York.<br /><searchLink fieldCode="AU" term="%22Kuwana+M%22">Kuwana M</searchLink>; Nippon Medical School Graduate School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Khanna+D%22">Khanna D</searchLink>; University of Michigan, Ann Arbor.<br /><searchLink fieldCode="AU" term="%22Hummers+L%22">Hummers L</searchLink>; John Hopkins University School of Medicine, Baltimore, Maryland.<br /><searchLink fieldCode="AU" term="%22Frech+TM%22">Frech TM</searchLink>; University of Utah and Salt Lake City VA Health Care System, Salt Lake City, Utah.<br /><searchLink fieldCode="AU" term="%22Stevens+W%22">Stevens W</searchLink>; St. Vincent's Hospital, Melbourne, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Matucci-Cerinic+M%22">Matucci-Cerinic M</searchLink>; Department of Experimental and Clinical Medicine, University of Florence, and Division of Rheumatology AOUC, Florence, and Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), IRCCS San Raffaele Hospital, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Kafaja+S%22">Kafaja S</searchLink>; David Geffen School of Medicine at University of California, Los Angeles (UCLA).<br /><searchLink fieldCode="AU" term="%22Distler+O%22">Distler O</searchLink>; University Hospital Zurich, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Jun+JB%22">Jun JB</searchLink>; Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Levy+Y%22">Levy Y</searchLink>; Meir Medical Center, Kfar Saba, Israel.<br /><searchLink fieldCode="AU" term="%22Leszcyzński+P%22">Leszcyzński P</searchLink>; Medyczne Centrum Hetmanska, Poznan, Poland.<br /><searchLink fieldCode="AU" term="%22Gordon+J%22">Gordon J</searchLink>; Weill Cornell Medical College, New York, New York.<br /><searchLink fieldCode="AU" term="%22Steen+V%22">Steen V</searchLink>; Georgetown University School of Medicine, Washington, DC.<br /><searchLink fieldCode="AU" term="%22Lee+EB%22">Lee EB</searchLink>; Seoul National University College of Medicine, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Jankowski+T%22">Jankowski T</searchLink>; Klinika Reumatologii Ukladowych Chorob Tkanki Lacznej Szpital Uniwersytecki, Bydgozzcz, Poland.<br /><searchLink fieldCode="AU" term="%22Litinsky+I%22">Litinsky I</searchLink>; Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Chung+L%22">Chung L</searchLink>; Stanford University School of Medicine and Palo Alto VA Health Care System, Palo Alto, California.<br /><searchLink fieldCode="AU" term="%22Hsu+V%22">Hsu V</searchLink>; Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey.<br /><searchLink fieldCode="AU" term="%22Mayes+M%22">Mayes M</searchLink>; McGovern Medical School, The University of Texas Health Science Center at Houston.<br /><searchLink fieldCode="AU" term="%22Sandorfi+N%22">Sandorfi N</searchLink>; Perelman School of Medicine at the University of Pennsylvania, Philadelphia.<br /><searchLink fieldCode="AU" term="%22Simms+RW%22">Simms RW</searchLink>; Boston University School of Medicine, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Finzel+S%22">Finzel S</searchLink>; Department of Rheumatology and Clinical Immunology, University Medical Center, Universitätsklinikum Freiburg, Freiburg, Germany.<br /><searchLink fieldCode="AU" term="%22de+Vries-Bouwstra+J%22">de Vries-Bouwstra J</searchLink>; Leiden University Medical Center, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Constantine+S%22">Constantine S</searchLink>; Corbus Pharmaceuticals, Inc., Norwood, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Dgetluck+N%22">Dgetluck N</searchLink>; Corbus Pharmaceuticals, Inc., Norwood, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Dinh+Q%22">Dinh Q</searchLink>; Corbus Pharmaceuticals, Inc., Norwood, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Bloom+BJ%22">Bloom BJ</searchLink>; Corbus Pharmaceuticals, Inc., Norwood, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Furst+DE%22">Furst DE</searchLink>; Department of Experimental and Clinical Medicine, University of Florence, and Division of Rheumatology AOUC, Florence, Italy, David Geffen School of Medicine at UCLA, Los Angeles, California, and University of Washington, Seattle, UK.<br /><searchLink fieldCode="AU" term="%22White+B%22">White B</searchLink>; Corbus Pharmaceuticals, Inc., Norwood, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Denton+CP%22">Denton CP</searchLink>; UCL Centre for Rheumatology and Connective Tissue Diseases, Royal Free Hospital Campus, University College London Medical School, London, UK.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22RESOLVE-1+Study+Group%22">RESOLVE-1 Study Group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101623795%22">Arthritis & rheumatology (Hoboken, N.J.)</searchLink> [Arthritis Rheumatol] 2023 Sep; Vol. 75 (9), pp. 1608-1618. <i>Date of Electronic Publication: </i>2023 Jun 15.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101623795 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2326-5205 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223265191%22">23265191 </searchLink><i>NLM ISO Abbreviation: </i>Arthritis Rheumatol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37098795
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/art.42510
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1608
    Titles:
      – TitleFull: Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Spiera R
      – PersonEntity:
          Name:
            NameFull: Kuwana M
      – PersonEntity:
          Name:
            NameFull: Khanna D
      – PersonEntity:
          Name:
            NameFull: Hummers L
      – PersonEntity:
          Name:
            NameFull: Frech TM
      – PersonEntity:
          Name:
            NameFull: Stevens W
      – PersonEntity:
          Name:
            NameFull: Matucci-Cerinic M
      – PersonEntity:
          Name:
            NameFull: Kafaja S
      – PersonEntity:
          Name:
            NameFull: Distler O
      – PersonEntity:
          Name:
            NameFull: Jun JB
      – PersonEntity:
          Name:
            NameFull: Levy Y
      – PersonEntity:
          Name:
            NameFull: Leszcyzński P
      – PersonEntity:
          Name:
            NameFull: Gordon J
      – PersonEntity:
          Name:
            NameFull: Steen V
      – PersonEntity:
          Name:
            NameFull: Lee EB
      – PersonEntity:
          Name:
            NameFull: Jankowski T
      – PersonEntity:
          Name:
            NameFull: Litinsky I
      – PersonEntity:
          Name:
            NameFull: Chung L
      – PersonEntity:
          Name:
            NameFull: Hsu V
      – PersonEntity:
          Name:
            NameFull: Mayes M
      – PersonEntity:
          Name:
            NameFull: Sandorfi N
      – PersonEntity:
          Name:
            NameFull: Simms RW
      – PersonEntity:
          Name:
            NameFull: Finzel S
      – PersonEntity:
          Name:
            NameFull: de Vries-Bouwstra J
      – PersonEntity:
          Name:
            NameFull: Constantine S
      – PersonEntity:
          Name:
            NameFull: Dgetluck N
      – PersonEntity:
          Name:
            NameFull: Dinh Q
      – PersonEntity:
          Name:
            NameFull: Bloom BJ
      – PersonEntity:
          Name:
            NameFull: Furst DE
      – PersonEntity:
          Name:
            NameFull: White B
      – PersonEntity:
          Name:
            NameFull: Denton CP
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2023 Sep
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2326-5205
          Numbering:
            – Type: volume
              Value: 75
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Arthritis & rheumatology (Hoboken, N.J.)
              Type: main
ResultId 1